Extracellular vimentin is a novel axonal growth facilitator for functional recovery in spinal cord-injured mice.
Vimentin, an intermediate filament protein, is an intracellular protein that is involved in various cellular processes. Several groups have recently reported that vimentin also appears in the extracellular space and shows novel protein activity. We previously reported that denosomin improved motor dysfunction in mice with a contusive spinal cord injury (SCI). At the injured area, astrocytes expressing and secreting vimentin were specifically increased, and axonal growth occurred in a vimentin-dependent manner in denosomin-treated mice. However, the axonal growth that was induced by extracellular vimentin was only investigated in vitro in the previous study. Here, we sought to clarify whether increased extracellular vimentin can promote the axonal extension related to motor improvement after SCI in vivo. Extracellular vimentin treatment in SCI mice significantly ameliorated motor dysfunction. In vimentin-treated mice, 5-HT-positive axons increased significantly at the rostral and central areas of the lesion, and the total axonal densities increased in the central and caudal parts of the lesioned area. This finding suggests that increased axonal density may contribute to motor improvement in vimentin-treated mice. Thus, our in vivo data indicate that extracellular vimentin may be a novel neurotrophic factor that enhances axonal growth activity and motor function recovery after SCI.
Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Michiko
M
Shigyo
Division of Neuromedical Science, Institute of Natural Medicine, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.
Chihiro
C
Tohda
D000818:Animals; D001369:Axons / Q000187:drug effects / Q000502:physiology*; D005260:Female; D051379:Mice; D009043:Motor Activity; D009414:Nerve Growth Factors / Q000008:administration & dosage*; D000071446:Neuronal Outgrowth / Q000187:drug effects; D020127:Recovery of Function; D013119:Spinal Cord Injuries / Q000188:drug therapy*; D014746:Vimentin / Q000008:administration & dosage*
D009414:Nerve Growth Factors; D014746:Vimentin